Drug
atezolizumab and hyaluronidase-tqjs
Marketed as TECENTRIQ HYBREZA.
Generic name
atezolizumab and hyaluronidase-tqjs
Brand names
TECENTRIQ HYBREZA
First FDA approval
2024-09-12
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761347 | TECENTRIQ HYBREZA | 2024-09-12 | GENENTECH INC |
Manufacturers
GENENTECH INC
Frequently asked questions
When was atezolizumab and hyaluronidase-tqjs FDA approved?
Earliest FDA approval on record: 2024-09-12.
What brand names are sold as atezolizumab and hyaluronidase-tqjs?
TECENTRIQ HYBREZA.
Sources
Appeal a atezolizumab and hyaluronidase-tqjs denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com